高萌科技(08065.HK)盈警:預計中期錄得除税前虧損約310萬港元
格隆匯10月26日丨高萌科技(08065.HK)公佈,預計集團截至2023年9月30日止六個月將錄得除税前虧損約310萬港元,而截至2022年9月30日止六個月的除税前虧損約為70萬港元。
該期間虧損較去年同期增加主要由於(其中包括)i)該期間整體毛利因材料成本和工程外判成本上升下降至大約17.1百萬港元(前期:大約1790萬港元),雖然該期間收入增加至大約9340萬港元(前期:大約7470萬港元);和ii)主因所得香港特別行政區政府保就業計劃項下之補助減少,該期間其他收入下跌至大約170萬港元(前期:大約540萬港元)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.